ACTIVE

TOBUFAR

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

380,9 k €

+20.8% YoY

Revenue

12,1 M €

Equity

5,8 M €

+7.0% YoY

Workforce

2,8 ETP

+21.7% YoY

What does TOBUFAR do?

TOBUFAR is a Private limited company incorporated in 1998. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Uccle. It employs on average 2,8 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0464.486.973

Incorporation

30/10/1998

Legal form

Private limited company

Registered office

Rue Joseph Bens 83A
1180 Uccle · BruxellesSee on map

Contributed capital

37 184,01 €

Latest accounts

31/12/2025

Average workforce

2,8 ETP

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods 51460Air transport

Joint committees (2)

321
32100

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Revenue	12,1 M €		–		14 M €	-0.7%	14,1 M €	-0.4%	14,2 M €	+6.7%	13,3 M €		–		11,5 M €	-25.8%	15,5 M €	+2.3%	15,1 M €	+20.6%	12,6 M €	+55.1%	8,1 M €	+34.8%	6 M €		–		–		–		–		17,2 M €	-44.1%	30,8 M €	+52.1%	20,2 M €
EBITDA	558,6 k €	+13.4%	492,6 k €	-24.1%	648,6 k €	-10.3%	723 k €	+44.7%	499,8 k €	-51.5%	1 M €	+84.4%	559 k €	-5.9%	594,1 k €	-23.4%	775,2 k €	-9.9%	860,7 k €	+26.6%	679,9 k €	+43.4%	474,1 k €	+106%	230,6 k €	+27.8%	180,4 k €	+55.0%	116,4 k €	-82.8%	675,9 k €	+55.3%	435,1 k €	+32.3%	328,9 k €	-62.4%	875,6 k €	+103%	431,8 k €
Operating result	486,3 k €	+18.0%	412,2 k €	-28.1%	573,3 k €	-11.4%	646,8 k €	+53.7%	420,7 k €	-55.4%	944,3 k €	+105%	461,1 k €	-4.7%	483,9 k €	-28.1%	672,7 k €	-11.7%	761,4 k €	+43.7%	529,7 k €	+41.4%	374,7 k €	+205%	122,9 k €	+62.0%	75,9 k €	+323%	18 k €	-97.1%	612,6 k €	+50.9%	405,9 k €	+61.8%	250,8 k €	-70.2%	843 k €	+104%	413,5 k €
Net result	380,9 k €	+20.8%	315,3 k €	-21.4%	400,9 k €	-16.2%	478,6 k €	+129%	209 k €	-70.3%	703,1 k €	+159%	271,7 k €	-12.2%	309,2 k €	-29.6%	439,3 k €	-12.9%	504,2 k €	+26.1%	399,9 k €	+45.1%	275,7 k €	+133%	118,4 k €	+108%	56,8 k €	-89.3%	533,3 k €	+34.6%	396,3 k €	+65.3%	239,7 k €	+15.8%	207 k €	-57.8%	490,6 k €	+52.4%	322 k €
Balance sheet
Equity	5,8 M €	+7.0%	5,4 M €	+1.0%	5,4 M €	+2.2%	5,2 M €	+10.1%	4,8 M €	+4.6%	4,6 M €	+18.3%	3,8 M €	+7.6%	3,6 M €	+9.5%	3,3 M €	+15.5%	2,8 M €	+21.7%	2,3 M €	+20.8%	1,9 M €	+16.7%	1,6 M €	-18.1%	2 M €	+2.9%	2 M €	+37.5%	1,4 M €	+15.4%	1,2 M €	+23.1%	1 M €	+22.4%	817,8 k €	+117%	377,2 k €
Total assets	7,5 M €	+10.8%	6,8 M €	-6.2%	7,2 M €	+12.3%	6,4 M €	+14.4%	5,6 M €	-0.1%	5,6 M €	+12.8%	5 M €	+4.8%	4,8 M €	+12.3%	4,2 M €	+0.6%	4,2 M €	+17.1%	3,6 M €	+28.8%	2,8 M €	-7.1%	3 M €	-13.1%	3,5 M €	+7.9%	3,2 M €	+1.9%	3,1 M €	+21.4%	2,6 M €	+44.8%	1,8 M €	-10.4%	2 M €	-18.8%	2,5 M €
Cash	745,7 k €	-6.1%	794,1 k €	+4.7%	758,6 k €	+11.5%	680,2 k €	-11.9%	772 k €	-50.6%	1,6 M €	+142%	645,5 k €	+109%	308,3 k €	+36.5%	225,9 k €	-61.2%	582,7 k €	+59.9%	364,5 k €	+51.2%	241 k €	-14.4%	281,6 k €	+73.3%	162,5 k €	-75.7%	667,8 k €	+96.0%	340,8 k €	+532%	53,9 k €	-85.4%	368,4 k €	-51.3%	755,8 k €	+33.3%	567,1 k €
Debts	1,7 M €	+25.7%	1,4 M €	-27.0%	1,9 M €	+57.4%	1,2 M €	+38.9%	853,4 k €	-20.1%	1,1 M €	-5.6%	1,1 M €	-3.8%	1,2 M €	+23.0%	955,7 k €	-30.1%	1,4 M €	+8.4%	1,3 M €	+45.7%	865,7 k €	-36.0%	1,4 M €	-6.1%	1,4 M €	+15.7%	1,2 M €	-27.2%	1,7 M €	+26.4%	1,4 M €	+72.7%	784,2 k €	-33.1%	1,2 M €	-43.5%	2,1 M €
Other
Workforce	2,8 ETP	+21.7%	2,3 ETP	+4.5%	2,2 ETP	0.0%	2,2 ETP	-4.3%	2,3 ETP	-8.0%	2,5 ETP	-21.9%	3,2 ETP	-8.6%	3,5 ETP	+59.1%	2,2 ETP	-8.3%	2,4 ETP	+9.1%	2,2 ETP	-21.4%	2,8 ETP	+21.7%	2,3 ETP	+21.1%	1,9 ETP	+18.7%	1,6 ETP	-44.8%	2,9 ETP	-3.3%	3,0 ETP	+20.0%	2,5 ETP	+31.6%	1,9 ETP	-9.5%	2,1 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 5 M€ and 10 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 7 ended

Active mandates

MEDCOLAB

Director · since 01 octobre 2011 · 0467.172.982

Represented by Antoon Vandenbulcke

Active

Ended mandates

MEDCOLAB

Director · since 08 juillet 2022 · 0467.172.982

Represented by Antoon Vandenbulcke

Ended

MEDCOLAB

Manager · since 01 octobre 2011 · 0467.172.982

Represented by Antoon Vandenbulcke

Ended

MEDCOLAB

Manager · since 01 octobre 2011 · 0467.172.982

Represented by Antoon Vandenbulcke

Ended

MEDCOLAB

Director · since 01 octobre 2011 · 0467.172.982

Represented by Antoon Vandenbulcke

Ended

At this address

Other companies at this address

Company	CBE no.
JC PHARMA● Active	0460.070.010

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Abridged model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	12/06/2026	18/07/2025	31/07/2024	09/06/2023	28/07/2022	26/05/2021
General meeting	12/05/2026	13/05/2025	14/05/2024	09/05/2023	10/05/2022	11/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	12/05/2026	12/06/2026	Dutch	PDF
Abridged model	31/12/2024	13/05/2025	18/07/2025	Dutch	PDF
Full model	31/12/2023	14/05/2024	31/07/2024	Dutch	PDF
Full model	31/12/2022	09/05/2023	09/06/2023	Dutch	PDF
Full model	31/12/2021	10/05/2022	28/07/2022	Dutch	PDF
Full model	31/12/2020	11/05/2021	26/05/2021	Dutch	PDF
Abridged model	31/12/2019	12/05/2020	08/06/2020	Dutch	PDF
Abridged model	31/12/2018	14/05/2019	13/06/2019	Dutch	PDF
Abridged model	31/12/2017	08/05/2018	14/05/2018	Dutch	PDF
Abridged model	31/12/2016	09/05/2017	20/06/2017	Dutch	PDF
Abridged model	31/12/2015	10/05/2016	04/07/2016	Dutch	PDF
Abridged model	31/12/2014	12/05/2015	23/06/2015	Dutch	PDF
Abridged model	31/12/2013	13/05/2014	04/06/2014	Dutch	PDF
Abridged model	31/12/2012	14/05/2013	23/05/2013	Dutch	PDF
Abridged model	31/12/2011	08/05/2012	11/06/2012	Dutch	PDF
Abridged model	31/12/2010	10/05/2011	23/08/2011	Dutch	PDF
Abridged model	31/12/2009	11/05/2010	22/06/2010	Dutch	PDF
Abridged model	31/12/2008	12/05/2009	22/07/2009	Dutch	PDF
Abridged model	31/12/2007	13/05/2008	12/06/2008	Dutch	PDF
Abridged model	31/12/2006	08/05/2007	30/07/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 5 M€ and 10 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 7 ended

Active mandates

MEDCOLAB

Director · since 01 octobre 2011 · 0467.172.982

Represented by Antoon Vandenbulcke

Active

Ended mandates

MEDCOLAB

Director · since 08 juillet 2022 · 0467.172.982

Represented by Antoon Vandenbulcke

Ended

MEDCOLAB

Manager · since 01 octobre 2011 · 0467.172.982

Represented by Antoon Vandenbulcke

Ended

MEDCOLAB

Manager · since 01 octobre 2011 · 0467.172.982

Represented by Antoon Vandenbulcke

Ended

MEDCOLAB

Director · since 01 octobre 2011 · 0467.172.982

Represented by Antoon Vandenbulcke

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates19/07/2022
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DIVERSEN - ONTSLAGEN - BENOEMINGEN
PDF
Restructuring10/01/2014
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Restructuring05/11/2013
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...) - DIVERSEN
PDF
Mandates21/02/2012
ONTSLAGEN - BENOEMINGEN
PDF
Registered office06/09/2007
MAATSCHAPPELIJKE ZETEL
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025380,9 k €↑
2024
Annual accounts 2024315,3 k €↓
2023
Annual accounts 2023400,9 k €↓
2022
Annual accounts 2022478,6 k €↑
2021
Annual accounts 2021209 k €↓
2020
Annual accounts 2020703,1 k €↑
2019
Annual accounts 2019271,7 k €↓
2018
Annual accounts 2018309,2 k €↓
2017
Annual accounts 2017439,3 k €↓
2016
Annual accounts 2016504,2 k €↑
2015
Annual accounts 2015399,9 k €↑
2014
Annual accounts 2014275,7 k €↑
2013
Annual accounts 2013118,4 k €↑
2012
Annual accounts 201256,8 k €↓
2011
Annual accounts 2011533,3 k €↑
2010
Annual accounts 2010396,3 k €↑
2009
Annual accounts 2009239,7 k €↑
2008
Annual accounts 2008207 k €↓
2007
Annual accounts 2007490,6 k €↑
2006
Annual accounts 2006322 k €
30/10/1998
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

TOBUFAR

Overview

What does TOBUFAR do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline